CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly grow ...
United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial
United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...
Aligos Therapeutics Announces $105 Million Private Placement Financing
Proceeds expected to fund the start of the ALG-000184 Phase 2 clinical studyFunding expected to extend cash runway into the second half of ...
The Manila Times2d
Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr - bupropion HCl) Patent Litigation
The settlement agreement resolves all outstanding patent litigation relating to AUVELITY.
CRISPR Therapeutics AG: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...
Morningstar2d
United Therapeutics Corp UTHR
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately ...
Business Wire2d
Aurion Biotech Appoints Donald Munoz as Chief Financial Officer
Aurion Biotech, Inc. (Aurion), whose mission is to restore vision to millions of patients with life-changing regenerative ...
ZEO ScientifiX Provides Business Update to Stockholders and the Investment Community
FORT LAUDERDALE, FL / ACCESSWIRE / February 11, 2025 / ZEO ScientifiX, Inc. ('ZEO' or the 'Company') (OTCQB:ZEOX), a clinical-stage biopharmaceutical company fo ...
Pharmabiz1d
PHC and CCRM collaborate to develop primary T-cell expansion culture processes to enhance efficiency and improve cell quality
PHC and CCRM collaborate to develop primary T-cell expansion culture processes to enhance efficiency and improve cell quality: Tokyo, Japan Tuesday, February 11, 2025, 14:00 Hrs [ ...
Epitopea Appoints Klaus Edvardsen M.D., Ph.D. as Chief Medical Officer
Klaus joins Epitopea after serving as Chief Development Officer (CDO) at Nykode Therapeutics, where he oversaw clinical development, regulatory affairs, and project management across oncology, ...